The GSTP1*A Ile105/Ala114 variant is considered to be a wild type. One of the other polymorphic variants, GSTP1*B Val105/Ala114, has been associated with the risk of developing various different kinds of cancer, including GC 16.
Se considera como silvestre a la variante GSTP1*A Ile105/Ala114; y de las otras variantes polimórficas, a la GSTP1*B Val105/Ala114 se le ha asociado con el riesgo a desarrollar diferentes tipos de cáncer, incluyendo al CG 16.